---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-014446"
form_type: "8-K"
ticker: "TELO"
cik: "0001971532"
company_name: "Telomir Pharmaceuticals, Inc."
filed_at: "2024-04-12T23:59:59+00:00"
generated_at: "2026-06-03T23:39:46.809657+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Telomir Pharma General Counsel Christos Nicholoudis resigns from GC and board effective April 10

## Summary
- Christos Nicholoudis resigned as General Counsel and board member effective April 10, 2024.
- Resignation was to pursue other activities; no disagreement with the company.
- No replacement for General Counsel or board vacancy announced in the filing.

## SEC filing metadata
- accession: 0001493152-24-014446
- form_type: 8-K
- ticker: TELO
- cik: 0001971532
- company_name: Telomir Pharmaceuticals, Inc.
- filed_at: 2024-04-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1971532/000149315224014446/0001493152-24-014446-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1971532/000149315224014446/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-014446
- JSON: https://secwatch.observer/filing/0001493152-24-014446.json
- Plain text: https://secwatch.observer/filing/0001493152-24-014446.txt

## Key facts
- Executive change
  Christos Nicholoudis resigned as Board Member at Telomir Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Board Member
  source text: On April 10, 2024, Telomir Pharmaceuticals, Inc. (the “Company”) received written notice of resignation from Christos Nicholoudis, Esq. resigning, with immediate effect, from his positions as the General Counsel and a member of the Board of Directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1971532/000149315224014446/0001493152-24-014446-index.htm
- Executive change
  Christos Nicholoudis resigned as General Counsel at Telomir Pharmaceuticals, Inc..
  - Action: resigned
  - Role: General Counsel
  source text: On April 10, 2024, Telomir Pharmaceuticals, Inc. (the “Company”) received written notice of resignation from Christos Nicholoudis, Esq. resigning, with immediate effect, from his positions as the General Counsel and a member of the Board of Directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1971532/000149315224014446/0001493152-24-014446-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.